TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA3E/TUBA4A (Ab-272) Antibody

What is the TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA3E/TUBA4A (Ab-272) antibody and what does it target?

The TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA3E/TUBA4A (Ab-272) antibody is a rabbit polyclonal antibody designed to recognize multiple α-tubulin isotypes. Specifically, it targets the region around the phosphorylation site of tyrosine 272 (A-T-Y(p)-A-P) in human TUBA1/3/4. This antibody recognizes a highly conserved epitope present across several tubulin isotypes, making it useful for general tubulin studies but potentially limiting its specificity for individual isotype research. The antibody is raised in rabbits against a synthesized non-phosphopeptide derived from the target proteins, ensuring recognition of the native protein structure in experimental contexts .

What are the recommended applications for this antibody?

The antibody has been validated for use in Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) applications. For ELISA, the recommended dilution range is 1:2000-1:10000, while for Western Blot applications, the optimal dilution range is 1:500-1:3000. These dilution ranges have been established to balance signal strength with background minimization in typical research scenarios. The antibody's performance in immunohistochemistry, immunofluorescence, or flow cytometry applications has not been explicitly confirmed in the provided data, though similar antibodies targeting tubulin are often versatile across multiple immunological techniques .

What species reactivity does the antibody demonstrate?

The antibody shows confirmed reactivity with human and mouse samples, making it suitable for research using cell lines or tissues from these species. This cross-species reactivity is expected due to the highly conserved nature of tubulin proteins across mammalian species. The conservation of the epitope sequence (around tyrosine 272) contributes to this cross-reactivity, though researchers should validate the antibody when using it with other species not explicitly listed in the specifications .

How should the antibody be stored and handled?

Upon receipt, the antibody should be stored at -20°C or -80°C to maintain its activity. Repeated freeze-thaw cycles should be avoided as they can compromise antibody integrity and performance. The antibody is supplied in phosphate buffered saline (without Mg²⁺ and Ca²⁺), pH 7.4, containing 150mM NaCl, 0.02% sodium azide, and 50% glycerol. This formulation helps maintain stability during storage. When working with the antibody, it should be kept on ice or at 4°C to preserve its activity throughout the experimental procedure .

What challenges exist in studying individual tubulin isotypes and how can they be addressed?

Studying individual tubulin isotypes presents significant challenges due to their high sequence homology. For instance, TUBA1A shares 99.5% homology with TUBA1B α-tubulin, with only two distinct amino acids between them. This extreme similarity makes it difficult to develop truly isotype-specific antibodies, as most commercial "TUBA1A" antibodies bind to multiple isotypes. Researchers have addressed this challenge by developing tagged constructs, such as hexahistidine (His6)-tagged TUBA1A, where the tag is inserted into an internal loop between residues I42 and G43. This approach allows for specific visualization without disrupting tubulin function, unlike N- or C-terminal tags which can impair protein functionality. When studying specific isotypes, researchers should consider using genetic approaches (such as isotype-specific knockdowns) in combination with antibody-based detection methods for more reliable results .

How can the Ab-272 antibody be validated for flow cytometry applications?

For validating the Ab-272 antibody in flow cytometry applications, researchers should implement a comprehensive validation protocol that includes at least three experimental conditions:

• IgG Negative Control: Untreated cells with an isotype-matched IgG antibody to establish baseline fluorescence and non-specific binding

• Test Sample with Primary Antibody: Cells treated with the Ab-272 antibody

• Positive Control: Cells known to express the target proteins at detectable levels

The validation protocol should follow these methodological steps:

• Prepare cells appropriately (fixation/permeabilization)

• Block with suitable buffer to reduce non-specific binding

• Incubate with primary antibody at 4°C (4 hours to overnight)

• Wash thoroughly (at least 3 times) with cold antibody buffer

• Incubate with fluorophore-conjugated secondary antibody (2 hours at 4°C)

• Wash thoroughly before analysis

• Include controls to set voltage ranges for the appropriate laser and filter combinations

This validation approach ensures that any signal detected is specific to the target protein rather than resulting from non-specific binding or autofluorescence .

What are the considerations for using this antibody in studies of neuronal microtubule dynamics?

When using the Ab-272 antibody for neuronal microtubule studies, researchers should consider several important factors:

• Isotype Promiscuity: This antibody recognizes multiple α-tubulin isotypes, which may complicate interpretation when studying isotype-specific functions in neurons. Complementary approaches such as isotype-specific genetic manipulations should be considered.

• Post-translational Modifications: Neurons exhibit various tubulin post-translational modifications (PTMs) that affect microtubule stability and function. The Ab-272 antibody targets a region around tyrosine 272, and researchers should investigate whether PTMs near this region affect antibody binding.

• Developmental Context: TUBA1A expression is highest during neuronal development. Studies examining developmental processes should account for changing expression levels of different tubulin isotypes.

• Subcellular Localization: Different tubulin isotypes may show preferential localization to specific neuronal compartments. Immunofluorescence studies should carefully examine distribution patterns in dendrites, axons, and growth cones.

• Complementary Markers: Co-staining with markers for acetylated tubulin or other stabilized microtubule populations can provide additional context for interpreting Ab-272 antibody staining patterns in neurons .

How should researchers design Western blot experiments using this antibody?

For optimal Western blot results with the Ab-272 antibody, researchers should follow this methodological approach:

• Sample Preparation:

  • Extract proteins using a lysis buffer containing protease inhibitors

  • Determine protein concentration using Bradford or BCA assay

  • Prepare 20-40μg of total protein per lane

  • Denature samples in loading buffer containing SDS and β-mercaptoethanol at 95°C for 5 minutes

• Gel Electrophoresis and Transfer:

  • Use 10-12% polyacrylamide gels for optimal resolution of tubulin proteins (~50 kDa)

  • Include molecular weight markers

  • Transfer proteins to PVDF or nitrocellulose membranes at 100V for 1-2 hours or 30V overnight

• Antibody Incubation:

  • Block membrane with 5% non-fat milk or BSA in TBST for 1 hour at room temperature

  • Dilute Ab-272 antibody at 1:500-1:3000 in blocking buffer

  • Incubate membrane with diluted antibody overnight at 4°C

  • Wash membrane 3-5 times with TBST, 5 minutes each

  • Incubate with HRP-conjugated secondary antibody (anti-rabbit) at 1:5000-1:10000 for 1 hour at room temperature

  • Wash thoroughly 3-5 times with TBST

• Detection and Analysis:

  • Apply ECL substrate and expose to X-ray film or capture using a digital imaging system

  • Expected band size for α-tubulin is approximately 50 kDa

  • Include positive controls (brain tissue extracts are recommended) and loading controls (GAPDH, β-actin) .

What controls are essential when using this antibody for immunological assays?

When using the Ab-272 antibody in immunological assays, the following controls are essential:

• Negative Controls:

  • Isotype control: Use rabbit IgG at the same concentration as the primary antibody

  • No primary antibody control: Process samples following the same protocol but omit the primary antibody

  • Blocking peptide competition: Pre-incubate the antibody with excess blocking peptide (A-T-Y(p)-A-P) to demonstrate binding specificity

• Positive Controls:

  • Samples known to express α-tubulin isotypes (nearly all mammalian cells)

  • Brain tissue extracts (particularly for TUBA1A)

  • Positive reference samples from previous successful experiments

• Technical Controls:

  • Loading controls (for Western blot)

  • Staining controls for subcellular structures (for immunofluorescence)

  • Dilution series to determine optimal antibody concentration

• Validation Controls:

  • Samples with siRNA/shRNA knockdown of target proteins

  • Samples with overexpression of target proteins

  • Comparison with other antibodies targeting different epitopes of the same proteins

Implementation of these controls helps ensure experimental validity and aids in the interpretation of results, particularly when investigating subtle differences in tubulin isotype expression or localization .

How can researchers address cross-reactivity issues when studying specific tubulin isotypes?

Addressing cross-reactivity issues when studying specific tubulin isotypes requires a multi-faceted approach:

• Complementary Genetic Methods:

  • Use isotype-specific siRNA/shRNA knockdowns to verify antibody specificity

  • Generate isotype-specific knockout cell lines using CRISPR/Cas9

  • Perform rescue experiments with tagged versions of specific isotypes

• Alternative Tagging Strategies:

  • Utilize internal tagging approaches, such as the His6 tag inserted between residues I42 and G43, which has been shown to maintain tubulin functionality

  • Consider using epitope tags that can be detected with highly specific antibodies

  • Avoid N- or C-terminal tags as they can disrupt tubulin function

• Advanced Biochemical Approaches:

  • Perform immunoprecipitation with isotype-specific antibodies followed by mass spectrometry

  • Use 2D gel electrophoresis to separate tubulin isotypes based on both molecular weight and isoelectric point

  • Consider using recombinant expression systems for individual isotypes as standards

• Analytical Controls:

  • Include samples with known expression patterns of different isotypes

  • Perform parallel experiments with multiple antibodies targeting different epitopes

  • Validate findings using orthogonal techniques (e.g., RNA-seq for mRNA expression) .

What factors might affect the binding efficiency of the Ab-272 antibody?

Several factors can influence the binding efficiency of the Ab-272 antibody:

• Post-translational Modifications: Since the antibody targets a region around tyrosine 272, phosphorylation or other modifications at or near this site might alter epitope accessibility or antibody affinity. The antibody was raised against a non-phosphopeptide, so phosphorylation status may particularly impact binding.

• Protein Conformation: The three-dimensional structure of tubulin within microtubules versus free tubulin dimers might affect epitope exposure. Fixation methods can influence protein conformation and subsequent antibody binding.

• Sample Preparation: Different lysis buffers, fixation protocols, or antigen retrieval methods can impact epitope preservation and accessibility:

  • Formaldehyde fixation may preserve structure but can mask epitopes

  • Methanol fixation may better expose some tubulin epitopes but disrupt certain cellular structures

  • Antigen retrieval methods may be necessary for certain applications

• Buffer Conditions: Ionic strength, pH, and the presence of detergents can all affect antibody-antigen interactions:

  • Optimal binding typically occurs at physiological pH (7.2-7.4)

  • High salt concentrations may disrupt electrostatic interactions

  • Different blocking agents (BSA vs. milk proteins) may yield different results

• Incubation Parameters: Temperature, time, and antibody concentration all play crucial roles:

  • Longer incubation at 4°C often improves signal-to-noise ratio

  • Higher antibody concentrations may increase non-specific binding

  • Insufficient incubation time may result in weak signal .

How can researchers troubleshoot weak or absent signals when using this antibody?

When encountering weak or absent signals with the Ab-272 antibody, researchers should systematically investigate the following potential causes and solutions:

• Antibody Concentration:

  • Problem: Too dilute antibody solution

  • Solution: Titrate the antibody to determine optimal concentration; try concentration ranges from 1:250 to 1:3000 for Western blot

• Protein Abundance:

  • Problem: Low expression of target proteins

  • Solution: Increase total protein loading (up to 50-60μg); use tissue/cells known to express high levels of α-tubulin (e.g., brain tissue) as positive control

• Epitope Accessibility:

  • Problem: Masked or degraded epitope

  • Solution: Try different fixation methods; consider antigen retrieval techniques; ensure samples are properly denatured for Western blot

• Detection System Sensitivity:

  • Problem: Insufficient detection sensitivity

  • Solution: Use more sensitive detection reagents; increase exposure time; consider amplification systems (e.g., biotin-streptavidin)

• Antibody Quality:

  • Problem: Degraded antibody

  • Solution: Avoid repeated freeze-thaw cycles; store aliquots of antibody; ensure proper storage at -20°C or -80°C

• Incubation Conditions:

  • Problem: Suboptimal binding conditions

  • Solution: Extend primary antibody incubation (overnight at 4°C); optimize buffer composition; ensure gentle agitation during incubation

• Technical Issues:

  • Problem: Incomplete transfer (for Western blot)

  • Solution: Verify transfer efficiency using reversible protein stains; optimize transfer conditions; ensure good contact between gel and membrane .

What are the best practices for quantifying tubulin isotype expression levels using this antibody?

For accurate quantification of tubulin isotype expression using the Ab-272 antibody, researchers should adhere to these best practices:

How can this antibody contribute to studying neuronal development and disease models?

The Ab-272 antibody can make valuable contributions to neuronal development and disease model research in several ways:

• Developmental Studies:

  • Track changes in tubulin expression and distribution during neuronal differentiation

  • Examine microtubule dynamics in growing axons and dendrites

  • Study the role of tubulin in neuronal migration and cortex development

• Neurodegenerative Disease Models:

  • Investigate alterations in tubulin organization in models of Alzheimer's, Parkinson's, or ALS

  • Examine how disease-associated mutations affect tubulin stability and function

  • Study the interaction between tubulin and disease-associated proteins

• Tubulinopathy Research:

  • Explore cellular phenotypes associated with TUBA1A mutations linked to cortical malformations

  • Investigate compensatory mechanisms when specific tubulin isotypes are mutated

  • Examine how mutations affect post-translational modifications of tubulin

• Therapeutic Development:

  • Screen compounds that stabilize or modulate microtubule dynamics in disease models

  • Study the effects of microtubule-targeting drugs on specific neuronal populations

  • Investigate rescue strategies for tubulin-related pathologies

Research has shown that reduced Tuba1a is sufficient to support neuronal migration and cortex development but not commissure formation, highlighting the importance of specific tubulin isotypes in distinct developmental processes. The Ab-272 antibody, when used in conjunction with other molecular tools, can help elucidate the specific roles of tubulin isotypes in these processes .

What are the latest methodological advances in tubulin isotype-specific research?

Recent methodological advances in tubulin isotype-specific research have expanded our ability to study these highly similar proteins:

• Internal Tagging Strategies:

  • Development of internal tag insertion sites that maintain tubulin functionality

  • The hexahistidine (His6) tag inserted between residues I42 and G43 provides a model for studying specific isotypes

  • This approach overcomes limitations of N- or C-terminal tagging, which can disrupt protein function

• CRISPR/Cas9 Genome Editing:

  • Generation of isotype-specific knockout models

  • Introduction of point mutations that mimic disease-associated variants

  • Creation of endogenously tagged tubulin isotypes for live imaging

• Advanced Imaging Techniques:

  • Super-resolution microscopy to visualize individual microtubules

  • Live-cell imaging of tubulin dynamics with minimal photobleaching

  • Correlative light and electron microscopy to link tubulin distribution with ultrastructural features

• Isotype-Specific Biochemical Approaches:

  • Development of methods to purify specific tubulin isotypes

  • Mass spectrometry techniques to quantify isotype abundance and modifications

  • In vitro reconstitution systems using purified isotypes

• Computational Approaches:

  • Molecular dynamics simulations to predict isotype-specific properties

  • Systems biology approaches to model isotype expression networks

  • Machine learning applications for image analysis and phenotype classification

These methodological advances are overcoming the traditional challenges of studying highly homologous tubulin isotypes and opening new avenues for understanding their specific roles in cellular processes .

What is the significance of studying phosphorylation at tyrosine 272 in tubulin isotypes?

The phosphorylation of tyrosine 272 in tubulin isotypes represents a significant area of research with implications for microtubule dynamics and cellular function:

The Ab-272 antibody, which recognizes the region around tyrosine 272, provides a tool for investigating these aspects of tubulin biology and may contribute to our understanding of how phosphorylation regulates microtubule function in normal and disease states .

How does the TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA3E/TUBA4A (Ab-272) antibody compare with other tubulin antibodies?

A comparative analysis of the Ab-272 antibody with other commercially available tubulin antibodies reveals several key differences:

This comparison highlights that while the Ab-272 antibody offers advantages for general tubulin studies, researchers interested in isotype-specific analyses may need to employ complementary approaches or alternative antibodies depending on their specific research questions .

What experimental techniques can be combined with this antibody for comprehensive tubulin research?

For comprehensive tubulin research, the Ab-272 antibody can be effectively combined with various complementary techniques:

• Genetic Manipulation Approaches:

  • RNA interference (siRNA/shRNA) to knock down specific tubulin isotypes

  • CRISPR/Cas9 genome editing to create knockout or knock-in models

  • Overexpression systems with tagged tubulin variants

• Advanced Microscopy Techniques:

  • Super-resolution microscopy (STORM, PALM, SIM) for detailed microtubule organization

  • Live-cell imaging with fluorescently tagged tubulins for dynamics studies

  • FRAP (Fluorescence Recovery After Photobleaching) to measure tubulin turnover rates

  • Single-molecule tracking for detailed dynamics analysis

• Biochemical and Proteomic Approaches:

  • Co-immunoprecipitation to identify tubulin-interacting proteins

  • Mass spectrometry to characterize post-translational modifications

  • In vitro polymerization assays to assess microtubule assembly properties

  • Differential centrifugation to separate soluble from polymerized tubulin pools

• Functional Assays:

  • Cell migration assays to assess cytoskeletal function

  • Neurite outgrowth assays for neuronal studies

  • Mitotic spindle analysis for cell division research

  • Drug sensitivity tests to probe microtubule stability

• Computational and Systems Biology:

  • Network analysis of tubulin interactors

  • Structural modeling of isotype-specific properties

  • Image analysis algorithms for quantitative phenotyping

By integrating these approaches with antibody-based detection, researchers can overcome the limitations of any single method and develop a more comprehensive understanding of tubulin biology in their system of interest .

What are the cutting-edge research questions being addressed using tubulin antibodies in neuroscience?

Current cutting-edge research in neuroscience using tubulin antibodies like Ab-272 is addressing several important questions:

• Developmental Neurobiology:

  • How do specific tubulin isotypes contribute to neuronal migration and axon pathfinding?

  • What is the role of tubulin in establishing neuronal polarity?

  • How does the composition of tubulin isotypes change during brain development?

• Neurodegenerative Disease Mechanisms:

  • How do disease-associated mutations in tubulin affect microtubule stability and transport?

  • What role does tubulin play in the formation of protein aggregates in diseases like Alzheimer's?

  • Can modulation of tubulin post-translational modifications provide therapeutic benefits?

• Synaptic Plasticity and Function:

  • How do microtubules contribute to synaptic remodeling during learning and memory?

  • What is the role of specific tubulin isotypes in maintaining dendritic spine morphology?

  • How does activity-dependent regulation of tubulin affect neuronal connectivity?

• Brain Development Disorders:

  • What cellular mechanisms underlie cortical malformations caused by TUBA1A mutations?

  • How do tubulin isotypes contribute to commissure formation in the developing brain?

  • Can defects in specific tubulin isotypes be compensated by others during development?

• Neural Regeneration and Repair:

  • How can manipulation of tubulin dynamics promote axon regeneration after injury?

  • What role do tubulin post-translational modifications play in the growth of new neuronal processes?

  • Can targeted interventions in tubulin function enhance neuroplasticity?

Research has already shown that reduced Tuba1a is sufficient to support neuronal migration and cortex development but not commissure formation, highlighting the specific requirements for tubulin isotypes in different developmental processes. Further investigations using tools like the Ab-272 antibody, in combination with advanced techniques, continue to expand our understanding of these complex processes .